The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review
Open accessThe DOI matches its Crossref record; 46 of the 49 references it cites were found in a registry or an index; 104 of the 119 sources its claims cite were checked for support.
Abstract
Background: Older adults with cancer are amongst the most vulnerable population to be negatively impacted by COVID-19 due to their likelihood of comorbidities and compromised immune status. Considering the longevity of the pandemic, understanding the subjective perceptions and psychosocial concerns of this population may help ameliorate the psychological aftermath. In this review, we systematically analyze the literature surrounding the psychosocial impact and coping strategies among older adults with cancer within the context of COVID-19. Methods: We conducted a rapid review of literature following PRISMA guidelines between January 2020 to August 2021 using (1) MEDLINE, (2) Embase, (3) CINAHL, and (4) PsychINFO and keyword searches for “cancer” and “COVID-19” focused on adults 65 years or older. Results: Of the 6597 articles screened, 10 met the inclusion criteria. Based on the included articles, the psychosocial impact of COVID-19 was reported under four domains, (1) impact of COVID-19 on quality of life (QoL), (2) concerns related to COVID-19, (3) coping with the impact of COVID-19, and (4) recommendations for future care. Results pertaining to perceived quality of life were inconsistent across the included articles. The most common concerns related to: contracting COVID-19, survivorship transitions, and feelings of isolation. Coping strategies reported by older adults included: spiritual care, lived experience, acceptance, and positive reinterpretation. Conclusions: We found many psychosocial impacts of the pandemic on older adults with cancer. The findings from this review can inform interventions related to shared decision-making and tailored patient care in the future. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Overview
CoChat Summary
## TL;DR
This rapid review synthesized 10 studies on the psychosocial impact of COVID-19 on older adults with cancer and found mixed quality-of-life findings, but consistent concerns about isolation, cancer care disruptions, and infection risk. Common coping strategies included social connection, acceptance, spirituality, and positive reinterpretation.
## Key findings
- Of 6597 articles screened, 10 met inclusion criteria: 6 quantitative cross-sectional surveys, 3 qualitative studies, and 1 mixed-methods study.
- Psychosocial outcomes were inconsistent: some studies reported lower anxiety during lockdown in minimally affected areas (GAD-7 = 3.2 ± 4.5), while others found decreased quality of life and emotional functioning; one study reported depressive states of 35% vs. 31% between first and second lockdowns.
- Common concerns included loneliness/isolation, fear of contracting COVID-19, and changes in cancer care/access to healthcare; reported isolation increased from 18% before the pandemic to 67% during lockdown.
- Common coping strategies included acceptance (96.7%), self-distraction (93.3%), and taking action (93.3%), along with social connection, spirituality, and positive reinterpretation.
## Methods
- Rapid review conducted following systematic review methodology and PRISMA guidance; searches covered January 2020 to August 2021.
- Databases searched: MEDLINE, Embase, CINAHL, and PsychINFO; included peer-reviewed primary research in English, published since 2020, focused on older adults or samples with mean/median age ≥65.
- Study findings were narratively synthesized into four domains: QoL, COVID-19 concerns, coping, and future care recommendations; study quality was appraised with JBI, MMAT, or NIH tools depending on design.
## Limitations
- The paper states that included studies showed heterogeneity in cancer diagnosis and homogeneity in ethnicity and education within the sample.
- It notes that some surveys were administered online, so people with limited access to eHealth resources may have been disadvantaged.
- It states that the surveys lacked COVID-specific questionnaires to measure QoL.
- Evident from the text: the review used a streamlined rapid-review process with one reviewer for screening/data abstraction (verified by a second reviewer), which may increase the risk of missed or inconsistently interpreted studies compared with fully independent dual review.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
50 Valid · 7 Not valid · 7 Not checked · 12 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“79% of patients in one study reported being more afraid of their cancer than of COVID-19 [26].”
§ The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review > 3. Results > 3.2. Concerns Related to COVID-19
What the sources say
- Disputedcites [26] Catania, 2020, Fears and Perception of the Impact of COVID-19 on Patients with Lung Cancer: A Mono-Institutional Survey, Front. Oncol. sourceExperimental — accuracy not yet measured
Table 2 in the Results reports that 57.1% of the 156 lung cancer patients chose their oncological disease as their greater worry, not 79%; 16.7% chose both equally and 5.1% had missing responses. The paper’s statement that 21% were more afraid of COVID-19 cannot be inverted to say the remaining 79% were more afraid of cancer. (LLM, conf=0.95)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Factors associated with increased distress related to COVID-19 included being a woman (gender) (55%) (p < 0.001), presence of comorbidities (24%), being unpartnered, having received radiotherapy or surgery for lung cancer (30%), actively receiving intravenous treatment (72%) (p = 0.02), or receiving oral treatment not in their residence (90%), and being younger than 60 or aged 60–70 (p < 0.001) [2”
§ The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review > 3. Results > 3.2. Concerns Related to COVID-19
What the sources say
- Could not verifycites [23] Koinig, 2021, The cancer patient’s perspective of COVID-19-induced distress—A cross-sectional study and a longitudinal comparison of HRQOL assessed before and during the pandemic, Cancer Med. sourceExperimental — accuracy not yet measured
The Results sections on COVID-19 distress and its associations do not report whether receiving oral treatment away from home was associated with distress. Searches for oral treatment, residence, and treatment location found no such association; the paper’s 90% figure refers instead to patients who considered government rules justified. Page numbers were not available in our copy. (LLM, conf=0.74)
- Disputedcites [26] Catania, 2020, Fears and Perception of the Impact of COVID-19 on Patients with Lung Cancer: A Mono-Institutional Survey, Front. Oncol. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says patients on oral therapy received treatment resupplies at home and experienced relief from postponed hospital visits in over 90% of cases. The Abstract likewise describes relief, not increased COVID-19 distress. The claim reverses both the treatment location and the meaning of the 90% figure. (LLM, conf=0.91)
Checked by a reasoning model — may be wrong.
- Could not verifycites [27] Hyland, 2020, Behavioral and psychosocial responses of people receiving treatment for advanced lung cancer during the COVID-19 pandemic: A qualitative analysis, Psycho-Oncology sourceExperimental — accuracy not yet measured
Section 3.4 reports fear, loneliness and increased anxiety among some participants, but does not link distress to where oral treatment was received. The treatment characteristics in Section 3.3 do not report an oral-treatment location or a 90% figure; searches for those terms found no supporting passage. Page numbers were unavailable in our copy. (LLM, conf=0.76)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Factors associated with increased distress related to COVID-19 included being a woman (gender) (55%) (p < 0.001), presence of comorbidities (24%), being unpartnered, having received radiotherapy or surgery for lung cancer (30%), actively receiving intravenous treatment (72%) (p = 0.02), or receiving oral treatment not in their residence (90%), and being younger than 60 or aged 60–70 (p < 0.001) [2”
§ The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review > 3. Results > 3.2. Concerns Related to COVID-19
What the sources say
- Could not verifycites [23] Koinig, 2021, The cancer patient’s perspective of COVID-19-induced distress—A cross-sectional study and a longitudinal comparison of HRQOL assessed before and during the pandemic, Cancer Med. sourceExperimental — accuracy not yet measured
The Results section on associations of patients’ responses reports greater COVID-19 distress among female patients and those with impaired HRQOL, but does not report an association with intravenous treatment. Searches for “intravenous,” “72%,” and “p = 0.02” found no passage establishing the claimed treatment-related association or figures. (LLM, conf=0.76)
- Disputedcites [26] Catania, 2020, Fears and Perception of the Impact of COVID-19 on Patients with Lung Cancer: A Mono-Institutional Survey, Front. Oncol. sourceExperimental — accuracy not yet measured
In Results, “Worries About COVID-19” (page unavailable), the p = 0.02 comparison runs in the opposite direction: 25.5% of patients on oral treatment, versus 10% on intravenous treatment, reported being most worried about COVID-19. In Results, “Worries About the Impact of the COVID-19 Pandemic on Lung Cancer” (page unavailable), 72% of patients on intravenous treatment whose treatment was delayed reported being not at all or only a little worried about disease progression—not increased COVID-19 distress. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Could not verifycites [27] Hyland, 2020, Behavioral and psychosocial responses of people receiving treatment for advanced lung cancer during the COVID-19 pandemic: A qualitative analysis, Psycho-Oncology sourceExperimental — accuracy not yet measured
Section 3.4 reports anxiety and depressive symptoms among some participants, but does not link distress to intravenous treatment. The treatment table in Section 3.3 and the additional passages retrieved for “intravenous treatment,” “72%,” and “p = 0.02” provide no such association or statistical result. (LLM, conf=0.76)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Factors associated with increased distress related to COVID-19 included being a woman (gender) (55%) (p < 0.001), presence of comorbidities (24%), being unpartnered, having received radiotherapy or surgery for lung cancer (30%), actively receiving intravenous treatment (72%) (p = 0.02), or receiving oral treatment not in their residence (90%), and being younger than 60 or aged 60–70 (p < 0.001) [2”
§ The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review > 3. Results > 3.2. Concerns Related to COVID-19
What the sources say
- Disputedcites [23] Koinig, 2021, The cancer patient’s perspective of COVID-19-induced distress—A cross-sectional study and a longitudinal comparison of HRQOL assessed before and during the pandemic, Cancer Med. sourceExperimental — accuracy not yet measured
The Results (Figure 2 and the section on age, sex, and HRQOL) associate ages under 60 and 60–70 with greater limitations in everyday life, not with greater COVID-19 distress. Figure 2 explicitly says there were no age differences in responses to the other questions; the p < 0.001 value applies to everyday-life limitations among patients under 60. (LLM, conf=0.91)
Checked by a reasoning model — may be wrong.
- Could not verifycites [26] Catania, 2020, Fears and Perception of the Impact of COVID-19 on Patients with Lung Cancer: A Mono-Institutional Survey, Front. Oncol. sourceExperimental — accuracy not yet measured
The Results table of significant associations with COVID-19 worry lists gender, comorbidities, previous thoracic treatment, and treatment type, but not age. The patient-characteristics table reports age descriptively using a <75/≥75 split; searches for the claimed under-60 and 60–70 groups found no distress association or p < 0.001 for age. The reported p < 0.001 concerns previous surgery or pulmonary radiotherapy instead. (LLM, conf=0.76)
- Partly supportedcites [27] Hyland, 2020, Behavioral and psychosocial responses of people receiving treatment for advanced lung cancer during the COVID-19 pandemic: A qualitative analysis, Psycho-Oncology sourceExperimental — accuracy not yet measured
Section 3.4 reports that some patients felt scared and experienced increased anxiety or depressive symptoms during the pandemic. The paper gives a mean age in Table 1 but does not report distress associations for the under-60 or 60–70 age groups, or a p-value; its analysis is qualitative. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The surveys conducted to ascertain levels of anxiety and changes in perceived psychological well-being in patients with cancer during the lockdown suggested lower levels of anxiety (GAD-7 = 3.2 ± 4.5) in areas minimally affected by COVID-19 [20].”
§ The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review > 3. Results > 3.1. Impact of COVID-19 on Quality of Life (QoL)
What the sources say
- Partly supportedcites [20] Baffert, 2021, Quality of life of patients with cancer during the COVID-19 pandemic, In Vivo sourceExperimental — accuracy not yet measured
The Anxiety assessed by GAD-7 section reports a low mean score of 3.2±4.5, and the Conclusion places the study in an area minimally affected by COVID-19. But the Methods state that anxiety was assessed after lockdown, not during it; the authors explicitly say they did not evaluate anxiety during lockdown. (LLM, conf=0.90)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
40 more claims · 31 with their cited sources checked
Create a free account to see all 76 claims and to verify the 2 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 14
Citations
Cites
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223 · cited 1×
“To conduct this rapid review, we followed systematic review methodology and the updated preferred reporting items for systematic reviews and meta-analysis statement [12].”
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers
Hong, Q. N., Fàbregues, S., Bartlett, G., Boardman, F., Cargo, M., Dagenais, P., Gagnon, M.-P., Griffiths, F., Nicolau, B., O’Cathain, A., et al. (2018) · Education for Information · doi:10.3233/efi-180221 · Cited by 4,737 · cited 3×
“Older adults demonstrated resilience by maintaining social connectedness with family and friends either virtually [17] or through physically distant interactions [19].”
BackgroundMethodCancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Ai, Q., Lu, W., Liang, H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30096-6 · Cited by 4,384
Lockwood, C., Munn, Z., & Porritt, K. (2015) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000062 · Cited by 2,456 · cited 1×
“The Joanna Briggs Institute (JBI) critical appraisal tool [16] was used for qualitative studies; the mixed methods appraisal tool (MMAT) [17] was employed to assess mixed-method studies, and cross-sectional studies were appraised using NIH study quality assessment tool [18,19].”
MethodPsychosocial impact of COVID-19
Dubey, S., Biswas, P., Ghosh, R., Chatterjee, S., Dubey, M. J., Chatterjee, S., Lahiri, D., & Lavie, C. J. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.05.035 · Cited by 1,958 · cited 5×
“Setting up mental health facilities to mitigate pandemic-induced psychological impacts of any future eventualities can be of merit [10,46].”
InfluentialLi, S., Wang, Y., Xue, J., Zhao, N., & Zhu, T. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17062032 · Cited by 1,835
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Kuderer, N. M., Choueiri, T. K., Shah, D. P., Shyr, Y., Rubinstein, S. M., Rivera, D. R., Shete, S., Hsu, C.-Y., Desai, A., de Lima Lopes, G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31187-9 · Cited by 1,726
Lee, L. Y., Cazier, J.-B., Angelis, V., Arnold, R., Bisht, V., Campton, N. A., Chackathayil, J., Cheng, V. W., Curley, H. M., Fittall, M. W., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31173-9 · Cited by 1,103
Patt, D., Gordan, L., Diaz, M., Okon, T., Grady, L., Harmison, M., Markward, N., Sullivan, M., Peng, J., & Zhou, A. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.20.00134 · Cited by 646 · cited 1×
“In addition, the COVID-19 pandemic has caused significant disruption to the cancer care system, including a shift to virtual appointments, alternative treatment offerings, postponement of surveillance scans and surgeries, and diminished supportive care and survivorship services [6,7].”
Background
Research works printed but not linked: 2
- Dobbins, 2017, Rapid review guidebook, Natl. Collab. Cent. Method Tools, 13, 25
- Innovation, V.H. (2021, December 15). Covidence Systematic Review Software. Available online: http://www.covidence.org/.
Cited by
Puts, M. T. E., Alqurini, N., Strohschein, F. J., Koneru, R., Szumacher, E., Mariano, C. J., Monette, J., Hsu, T., Brennenstuhl, S., McLean, B., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.01007 · Cited by 83
The Level of COVID-19 Anxiety among Oncology Patients in Poland
Grajek, M. K., Krupa-Kotara, K. H., Rozmiarek, M., Sobczyk, K., Działach, E., Górski, M. K., & Kobza, J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191811418 · Cited by 19
Doege, D., Frick, J., Eckford, R. D., Koch‐Gallenkamp, L., Schlander, M., Baden‐Württemberg Cancer Registry, & Arndt, V. (2024) · International Journal of Cancer · doi:10.1002/ijc.35204 · Cited by 14
Supriati, L., Sudiana, I. K., Nihayati, H. E., Ahsan, Rodli, M., & Kapti, R. E. (2022) · SAGE Open Nursing · doi:10.1177/23779608221124294 · Cited by 13
Long-term effects of the COVID-19 pandemic for patients with cancer
Debie, Y., Palte, Z., Salman, H., Verbruggen, L., Vanhoutte, G., Chhajlani, S., Raats, S., Roelant, E., Vandamme, T., Peeters, M., et al. (2024) · Quality of Life Research · doi:10.1007/s11136-024-03726-9 · Cited by 10
Metadata
- Authors
- Verma, R., Kilgour, H. M., & Haase, K. R.
- Affiliations
- Cardiff University (GB)
- University of British Columbia (CA)
- Corresponding author
- Haase, Kristen R.
- Venue
- Current Oncology
- Publisher
- MDPI AG
- Published
- 2022-01-28
- Volume
- 29
- Issue
- 2
- Pages
- 589-601
- ISSN
- 1198-0052 (ISSN-L)
- 1718-7729
- PMC
- PMC8870801
- OpenAlex
- W4210562923
- Cited by
- 19
- References
- 49
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 7 · 2022: 5
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Current Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- cIRcle (University of British Columbia) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Keywords
- COVID-19 pandemic, older adults, cancer, psychosocial impact, coping strategies, quality of life, fear of infection, social isolation, spiritual care, acceptance, positive reappraisal, shared decision-making
- MeSH terms
- COVID-19, SARS-CoV-2, Aged, Humans, Neoplasms, Quality of Life, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review. https://app.cochat.ai/papers/10.3390/curroncol29020053
- The paper
- Verma, R., Kilgour, H. M., & Haase, K. R. (2022). The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review. Current Oncology. https://doi.org/10.3390/curroncol29020053
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

